Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value:
$10.17B
Total Bought:
$2.73B
Total Sold:
$1.63B
Net Transaction:
+$1.10B
Notable People:
Behzad Aghazadeh, Avoro Capital L.P.
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)2,022,2222,606,060+583,838$847.74M$1.27B12.48%+$422.07M
Ascendis Pharma A/SADR(ASND)5,110,0005,111,111+1,111$1.02B$1.09B10.71%+$73.97M
Madrigal Pharmaceuticals, Inc.(MDGL)1,833,0001,807,500-25,500$840.72M$1.05B10.35%+$211.86M
argenx SEADR(ARGX)990,000990,0000$730.18M$832.54M8.18%+$102.36M
Krystal Biotech, Inc.(KRYS)2,777,7772,888,888+111,111$490.36M$712.23M7.00%+$221.87M
Arrowhead Pharmaceuticals, Inc.(ARWR)10,900,00010,625,000-275,000$375.94M$705.39M6.93%+$329.45M
Kymera Therapeutics, Inc.(KYMR)6,350,0007,474,747+1,124,747$359.41M$581.61M5.72%+$222.20M
Structure Therapeutics IncADS5,155,5556,555,555+1,400,000$144.36M$455.94M4.48%+$311.58M
Avidity Biosciences Inc7,645,0005,455,000-2,190,000$333.09M$393.47M3.87%+$60.38M
Centessa Pharmaceuticals PlcADS10,808,08014,555,555+3,747,475$262.10M$364.03M3.58%+$101.94M
Celcuity Inc.(CELC)03,111,111+3,111,111$0$310.30M3.05%+$310.30M
Apellis Pharmaceuticals Inc
COM
12,222,22212,222,2220$276.59M$307.02M3.02%+$30.43M
Vera Therapeutics, Inc.(VERA)6,210,0005,888,888-321,112$180.46M$298.21M2.93%+$117.75M
Spdr Series Trust - S&p BiotechETF
ST STR SP BIOT
02,100,000+2,100,000$0$256.05M2.52%+$256.05M
Xenon Pharmaceuticals Inc.(XENE)5,400,0005,424,444+24,444$216.81M$243.12M2.39%+$26.31M
Terns Pharmaceuticals Inc04,350,000+4,350,000$0$175.74M1.73%+$175.74M
Revolution Medicines, Inc.(RVMD)02,170,000+2,170,000$0$172.84M1.70%+$172.84M
uniQure N.V.(QURE)4,444,4446,150,000+1,705,556$259.42M$147.17M1.45%-$112.25M
Soleno Therapeutics Inc2,577,7772,900,000+322,223$174.26M$134.27M1.32%-$39.99M
Ocular Therapeutix, Inc.(OCUL)10,250,00010,777,777+527,777$119.82M$130.84M1.29%+$11.02M
Taysha Gene Therapies, Inc.(TSHA)21,700,00021,700,0000$70.96M$119.35M1.17%+$48.39M
Mind Medicine (Mindmed) Inc05,000,000+5,000,000$0$66.95M0.66%+$66.95M
PTC Therapeutics, Inc.(PTCT)0685,000+685,000$0$52.03M0.51%+$52.03M
Viridian Therapeutics, Inc.(VRDN)01,500,000+1,500,000$0$46.68M0.46%+$46.68M
Oruka Therapeutics, Inc.(ORKA)1,333,3401,333,3400$25.64M$40.41M0.40%+$14.77M
Alkermes plc(ALKS)2,240,0001,400,000-840,000$67.20M$39.17M0.39%-$28.03M
Apogee Therapeutics Inc0500,000+500,000$0$37.74M0.37%+$37.74M
Septerna, Inc.(SEPN)1,337,5001,337,5000$25.16M$37.29M0.37%+$12.13M
Lexeo Therapeutics, Inc.(LXEO)03,300,000+3,300,000$0$32.77M0.32%+$32.77M
MannKind Corporation(MNKD)4,468,8774,444,444-24,433$24.00M$25.20M0.25%+$1.20M
GH Research PLC(GHRS)01,800,000+1,800,000$0$22.86M0.22%+$22.86M
Incyte Corporation(INCY)0135,000+135,000$0$13.33M0.13%+$13.33M
Whitehawk Therapeutics, Inc.(WHWK)2,849,4022,849,4020$5.41M$6.90M0.07%+$1.48M
89bio Inc6,387,7900-6,387,790$93.90M$0—-$93.90M
Akero Therapeutics Inc3,955,5550-3,955,555$187.81M$0—-$187.81M
Amicus Therapeutics Inc.
COM
15,025,0000-15,025,000$118.40M$0—-$118.40M
BioCryst Pharmaceuticals, Inc.(BCRX)1,250,0000-1,250,000$9.49M$0—-$9.49M
Merus N V3,542,5000-3,542,500$333.53M$0—-$333.53M
MoonLake ImmunotherapeuticsCL A(MLTX)2,000,0000-2,000,000$14.34M$0—-$14.34M
Tango Therapeutics, Inc.(TNGX)545,0000-545,000$4.58M$0—-$4.58M
Tourmaline Bio Inc2,555,5550-2,555,555$122.23M$0—-$122.23M
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q4 2025 | TickerTrail